Europe Infectious Disease Diagnostics Market (2025-2030)
The Europe Infectious Disease Diagnostics Market was valued at $293.2 Million in 2025 and projected to reach to $439.1 Million by 2030, representing a compound annual growth rate of 8.4%. Europe's infectious disease diagnostics market is poised for steady expansion, driven by increasing prevalence of infectious diseases, aging populations, and heightened focus on rapid diagnostic capabilities.
Europe Infectious Disease Diagnostics Market Trends and Insights
- Rest Of Latin America is experiencing steady demand for diagnostic solutions driven by rising infectious disease prevalence, improved healthcare infrastructure, and increased investment in laboratory capabilities.
- The region's market growth reflects expanding access to molecular, immunological, and point-of-care testing platforms across both public and private healthcare systems. Rest Of Latin America's infectious disease diagnostics sector is characterized by growing adoption of rapid diagnostic tests and automation in clinical laboratories.
- Between 2025 and 2030, Rest Of Latin America will benefit from enhanced disease surveillance programs, regulatory support for diagnostic innovation, and partnerships with international diagnostic manufacturers.
- The market expansion in Rest Of Latin America is supported by rising healthcare expenditure and the region's commitment to strengthening infectious disease detection and management capabilities..
Key Market Statistics
- CAGR (2025-2030) 8.4% CAGR
- Market Size, 2025 ~USD 293.2 Million
- Forecast, 2030 ~USD 439.1 Million
- Geography Europe
Europe Infectious Disease Diagnostics Market Overview
Market Leadership :
Germany dominates Europe's infectious disease diagnostics market with USD 2,742.4 million in market size, driven by advanced healthcare infrastructure and strong R&D investments in diagnostic technologies.
Robust Growth Trajectory :
Europe's infectious disease diagnostics market is expanding at a CAGR of 8.4%, growing from USD 293.2 million in 2025 to USD 439.1 million by 2030, reflecting increasing disease surveillance needs.
Key Market Contributors :
The UK (USD 2,147.3 million), France (USD 1,085.2 million), and Italy (USD 822.9 million) are significant contributors, supported by stringent regulatory frameworks and high healthcare spending.
Emerging Opportunities :
Rest of Europe markets (USD 798.9 million) present growth opportunities through improved healthcare access, rising infectious disease awareness, and modernization of diagnostic laboratory infrastructure.
Europe Infectious Disease Diagnostics Market Dynamics
- The region benefits from well-established healthcare systems, significant investment in diagnostic innovation, and strong regulatory support for new technologies.
- Advanced molecular diagnostics, point-of-care testing, and automation are gaining traction across European healthcare facilities.
- The market is expected to reach USD 439.1 million by 2030, with Germany and the UK leading growth.
- Collaboration between diagnostic manufacturers and healthcare providers, coupled with digital health integration, will further accelerate market penetration and adoption of advanced infectious disease diagnostic solutions across the continent..
Related Ecosystem
In Vitro Diagnostics
Medical Devices
Key Takeaways
- Rest Of Latin America's infectious disease diagnostics market will grow from USD 293.2 million (2025) to USD 439.1 million (2030) at an 8.4% CAGR.
- Rest Of Latin America is witnessing increased adoption of rapid and molecular diagnostic tests across public and private healthcare facilities.
- Rest Of Latin America's market expansion is driven by rising infectious disease burden, improved laboratory infrastructure, and healthcare investment.
- Rest Of Latin America benefits from regulatory support and international partnerships that accelerate diagnostic innovation and market penetration.
Infectious Disease Diagnostics Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | MOSQUITO-BORNE DISEASES (Disease Type) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 9.7% from 2025 to 2030 |
| Largest Segment | LABORATORY TESTING (Type Of Testing) |
| Market Size Base Year (Billions) | ~USD 26.56 (2025) |
| Revenue Forecast (Billions) | ~USD 42.2 (2030) |
| Segments Covered | Product & Service, Type Of Testing, Sample Type, Disease Type, Type, Technology |
Europe Infectious Disease Diagnostics Market Report Segmentation
6 segment dimensions are covered across the global market.
By Product & Service
- Instruments
- Reagents, Kits, And Consumables
- Software & Services
By Type Of Testing
- Laboratory Testing
- Poc Testing
By Sample Type
- Blood, Serum, And Plasma
- Other Sample Types
- Urine
By Disease Type
- Chlamydia Trachomatis
- Hepatitis
- Hiv
- Hospital-Acquired Infections
- Hpv
- Influenza
- Mosquito-Borne Diseases
- Neisseria Gonorrhea
- Other Infectious Diseases
- Syphilis
- Tuberculosis
By Type
- Hepatitis B
- Hepatitis C
- Other Hepatitis Diseases
By Technology
- Clinical Microbiology
- Dna Microarray
- Dna Sequencing & Next-Generation Sequencing
- Immunodiagnostics
- Isothermal Nucleic Acid Amplification Technology
- Other Technologies
- Polymerase Chain Reaction
Target Audience
- Diagnostic Device Manufacturers : Need market sizing and growth forecasts to identify expansion opportunities, prioritize European markets, and develop region-specific product strategies for infectious disease diagnostics.
- Healthcare Providers & Laboratories : Require market intelligence to benchmark diagnostic capabilities, evaluate emerging technologies, and make informed procurement decisions aligned with market trends and patient needs.
- Investment & Private Equity Firms : Seek comprehensive market data to evaluate investment opportunities, assess portfolio company positioning, and identify acquisition targets in Europe's growing diagnostics sector.
- Regulatory & Policy Bodies : Need market insights to develop evidence-based healthcare policies, understand diagnostic adoption rates, and ensure appropriate regulatory frameworks for infectious disease testing.
- Consulting & Research Organizations : Utilize detailed European market data to support client advisory services, competitive analysis, and strategic recommendations in the infectious disease diagnostics space.
Key Companies in the Europe Infectious Disease Diagnostics Market
| Company | HQ | Ownership | Strongest segments |
|---|
Countries within Europe - compare and drill down
| Country | 2025 size (native) |
|---|---|
| Germany | USD 2742.4 Million |
| UK | USD 2147.3 Million |
| France | USD 1085.2 Million |
| Italy | USD 822.9 Million |
| Spain | USD 602.9 Million |
| Rest Of Europe | USD 798.9 Million |
Country market size visualization
Reasons to Buy this Report
- Country-Level Market Insights : Detailed market sizing and forecasts for Germany, UK, France, Italy, Spain, and Rest of Europe, enabling precise market targeting and regional strategy development.
- Competitive Landscape Analysis : Comprehensive understanding of market dynamics, key players, and competitive positioning specific to European infectious disease diagnostics, supporting informed business decisions.
- Growth Opportunity Identification : Identify high-growth segments and emerging markets within Europe, including underserved regions in Rest of Europe with significant expansion potential through 2030.
- Regulatory & Market Trends : Insights into European regulatory frameworks, reimbursement policies, and adoption trends for advanced diagnostic technologies across different healthcare systems.
- Strategic Planning Support : Data-driven intelligence for market entry, expansion, partnership, and investment decisions in Europe's infectious disease diagnostics sector with 8.4% CAGR growth.
Frequently asked questions
What is the market size of infectious disease diagnostics in Rest Of Latin America?
Rest Of Latin America's infectious disease diagnostics market is estimated at USD 293.2 million in 2025 and is forecast to reach USD 439.1 million by 2030.
What is the growth rate for infectious disease diagnostics in Rest Of Latin America?
Rest Of Latin America's infectious disease diagnostics market is projected to grow at a CAGR of 8.4% from 2025 to 2030.
What diagnostic technologies are driving growth in Rest Of Latin America?
Rest Of Latin America's market growth is driven by adoption of molecular diagnostics, rapid point-of-care tests, immunological assays, and automated laboratory systems.
Which factors are accelerating market expansion in Rest Of Latin America?
Rest Of Latin America's market expansion is accelerated by rising infectious disease prevalence, increased healthcare spending, laboratory modernization, and regulatory support for diagnostic innovation.
How is Rest Of Latin America's market positioned relative to other Latin American regions?
Rest Of Latin America represents a significant portion of the broader Latin American infectious disease diagnostics market, with steady growth supported by regional healthcare infrastructure improvements and disease surveillance initiatives.
RESEARCH METHODOLOGY
The study analyzes key market dynamics, such as drivers, opportunities, restraints, challenges, and key player strategies. The objectives include tracking company developments such as acquisitions, product/service launches & approvals, expansions, agreements, and partnerships of the leading players. These parameters were evaluated on various parameters within the broad business & product strategy categories. Top-down and bottom-up approaches were used to estimate the market size. The market breakdown and data triangulation were used to estimate the market size of segments and subsegments.
The four steps involved in estimating the market size are:
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify & collect information for this study.
Primary Research
In the primary research process, various sources from both the supply & demand sides were interviewed to obtain qualitative & quantitative information for this report. Primary sources included experts from the core & related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain & verify critical qualitative & quantitative information and assess prospects.
The following is a breakdown of the primary respondents:
Note 1: Others include sales, marketing, and product managers.
Note 2: Companies are classified into tiers based on their total revenues. As of 2024, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = < USD 10 million.
To know about the assumptions considered for the study, download the pdf brochure
| COMPANY NAME | DESIGNATION |
|---|---|
| Abbott (US) | Sales Manager |
| Becton, Dickinson and Company (US) | Product Manager |
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate & validate the infectious disease diagnostics market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry have been identified through extensive secondary research
- The revenues generated by leading players operating in the infectious disease diagnostics market have been determined through primary & secondary research.
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
The research methodology used to estimate the market size includes the following:
Data Triangulation
After arriving at the overall market size by applying the abovementioned process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Infectious disease diagnostics can be defined as various techniques and products (including kits, assays, tests, reagents, and analyzers) used by healthcare professionals to detect and diagnose disease-causing pathogens in human samples such as serum, blood, urine, throat swabs, and stool, among others.
Stakeholders
- Manufacturers & distributors of infectious disease diagnostics
- IVD companies
- Hospitals & clinics
- Academic research institutes
- Diagnostic laboratories
- Blood banks
- Home health agencies
- Market research & consulting firms
- Government associations
- Venture capitalists & investors
Report Objectives
- To define, describe, segment, and forecast the global infectious disease diagnostics market by product & service, type of testing, sample type, disease type, technology, clinical application, end user, and region
- To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall infectious disease diagnostics market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the market segments with respect to five regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To track and analyze company developments such as product launches & approvals, partnerships, acquisitions, agreements, and other developments
- To benchmark players within the infectious disease diagnostics market using the Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings
Get the Full Infectious Disease Diagnostics Market Report
Full forecast, segment splits, and company analysis for all Infectious Disease Diagnostics Market.
- US Infectious Disease Diagnostics Market
- Canada Infectious Disease Diagnostics Market
- Germany Infectious Disease Diagnostics Market
- UK Infectious Disease Diagnostics Market
- France Infectious Disease Diagnostics Market
- Italy Infectious Disease Diagnostics Market
- Spain Infectious Disease Diagnostics Market
- China Infectious Disease Diagnostics Market
- Japan Infectious Disease Diagnostics Market
- India Infectious Disease Diagnostics Market
- Brazil Infectious Disease Diagnostics Market
- Mexico Infectious Disease Diagnostics Market
- United Arab Emirates Infectious Disease Diagnostics Market
- Rest Of Europe Infectious Disease Diagnostics Market
- Rest Of Asia Pacific Infectious Disease Diagnostics Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report